Increased 2',5'-oligoadenylate synthetase activity in blood mononuclear leukocytes from patients with advanced cutaneous T-cell lymphoma.

[1]  E. Vonderheid,et al.  2',5'-oligoadenylate synthetase from cutaneous T-cell lymphoma: biosynthesis, identification, quantitation, molecular size of the 2',5'-oligoadenylates, and inhibition of protein synthesis. , 1983, Biochemistry.

[2]  W. Blattner,et al.  Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. , 1983, The New England journal of medicine.

[3]  K. O'Neill,et al.  Natural cell-mediated cytotoxicity in cutaneous T-cell lymphomas. , 1983, The Journal of investigative dermatology.

[4]  W. Blattner,et al.  Association of the human type C retrovirus with a subset of adult T-cell cancers. , 1983, Cancer research.

[5]  F. Real,et al.  Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. , 1983, The New England journal of medicine.

[6]  M. Degré,et al.  Interferon in suction blister fluid from psoriatic lesions , 1983, The British journal of dermatology.

[7]  D. Mann,et al.  Isolation and transmission of human retrovirus (human t-cell leukemia virus). , 1983, Science.

[8]  S. Hughes,et al.  Decreased natural-killer-cell activity in cutaneous T-cell lymphomas. , 1983 .

[9]  M. Reitz,et al.  Human retroviruses and adult T-cell leukemia-lymphoma. , 1982, Journal of the National Cancer Institute.

[10]  S. Morrison,et al.  Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. , 1982, The Journal of clinical investigation.

[11]  M. Robert-Guroff,et al.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. , 1982, Science.

[12]  M. Reitz,et al.  The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group , 1982, Nature.

[13]  J. Goedert,et al.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. , 1982, The Journal of infectious diseases.

[14]  W. Blattner,et al.  The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphoma , 1982, International journal of cancer.

[15]  M. Aboud,et al.  Effect of mouse interferon on retrovirus production by chronically infected rat cells. , 1982, Antiviral research.

[16]  W. Vloten,et al.  Functions of peripheral‐blood monocytes and granulocytes in cutaneous T‐cell lymphoma , 1982, The British journal of dermatology.

[17]  R. Warnke,et al.  Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia. , 1982, Blood.

[18]  R. Friedman,et al.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. , 1982, Science.

[19]  S. Ohno,et al.  Detection of gamma interferon in the sera of patients with Behçet's disease , 1982, Infection and immunity.

[20]  T. Schnitzer,et al.  Serum interferon levels in patients with systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[21]  M. Greaves,et al.  ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES , 1982, The Lancet.

[22]  Y. Ito,et al.  Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia. , 1982, Science.

[23]  T. Chang,et al.  Cellular origin and interactions involved in gamma-interferon production induced by OKt3 monoclonal antibody. , 1982, Journal of immunology.

[24]  P. Nowell,et al.  Clonal Characteristics of Cutaneous T Cell Lymphomas: Cytogenetic Evidence from Blood, Lymph Nodes, and Skin , 1982 .

[25]  T. Merigan,et al.  Interferon: Immunobiology and Clinical Significance , 1982 .

[26]  D. Wallach,et al.  Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia. , 1982, Journal of interferon research.

[27]  B. Haynes,et al.  Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease. , 1982, Blood.

[28]  J. Armstrong,et al.  Depression of natural killer cell activity by interferon. , 1981, The Journal of infectious diseases.

[29]  T. Hahn,et al.  Evaluation of the human interferon system in viral disease. , 1981, Clinical and experimental immunology.

[30]  M. Robert-Guroff,et al.  Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody , 1981, The Journal of experimental medicine.

[31]  J. Minna,et al.  Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus , 1981, Nature.

[32]  M. Reitz,et al.  Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia , 1981, Nature.

[33]  D. Wallach,et al.  ASSAY OF AN INTERFERON-INDUCED ENZYME IN WHITE BLOOD CELLS AS A DIAGNOSTIC AID IN VIRAL DISEASES , 1981, The Lancet.

[34]  J. Groopman,et al.  Immune (γ) interferon produced by a human T-lymphoblast cell line , 1981, Nature.

[35]  P. Bunn,et al.  Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas , 1981, The Journal of experimental medicine.

[36]  G. Riethmüller,et al.  Natural killer cell activity during treatment with fibroblast interferon. , 1981, Immunobiology.

[37]  B. Haynes,et al.  Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. , 1981, The New England journal of medicine.

[38]  P. Doetsch,et al.  Synthesis and characterization of (2′-5′)ppp3′dA(p3′dA)n, an analogue of (2′-5′)pppA(pA)n , 1981, Nature.

[39]  J. Parry,et al.  INTERFERON ASSAY AS A DIAGNOSTIC TEST , 1981, The Lancet.

[40]  L. Montagnier,et al.  Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells. , 1981, Journal of interferon research.

[41]  D. Wallach,et al.  The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products. , 1981, Analytical biochemistry.

[42]  D. Wallach,et al.  Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells. , 1981, Journal of interferon research.

[43]  S. Pestka,et al.  Augmentation of Human K‐Cell Activity with Interferon , 1980, Scandinavian journal of immunology.

[44]  S. Pestka,et al.  ROLE OF INTERFERON IN REGULATION OF CYTOTOXICITY BY NATURAL KILLER CELLS AND MACROPHAGES , 1980, Annals of the New York Academy of Sciences.

[45]  R. Miller,et al.  Sézary syndrome: a model for migration of T lymphocytes to skin. , 1980, The New England journal of medicine.

[46]  Michael David,et al.  Cell‐mediated immunity in patients with mycosis fungoides in clinical remission. Effect of thymic humoral factor on the immunocompetence of the lymphocytes , 1980, Cancer.

[47]  C. Meijer,et al.  C-Type virus-like particles specifically localized in langerhans cells and related cells of skin and lymph nodes of patients with mycosis fungoides and Sezary’s syndrome , 1979, Virchows Archiv. B, Cell pathology including molecular pathology.

[48]  A. Notkins,et al.  Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.

[49]  D. Warburton,et al.  Cutaneous T-cell lymphoma: neoplasm of T cells with helper activity. , 1979, Blood.

[50]  L. A. Ball,et al.  Nuclease activation by double-stranded RNA and by 2',5'-oligoadenylate in extracts of interferon-treated chick cells. , 1979, Virology.

[51]  W. Weston,et al.  Human monocyte chemotaxis: a quantitative in vivo technique. , 1979, The Journal of investigative dermatology.

[52]  J. Sosman,et al.  Enhancement of T cell cytotoxic responses by purified human fibroblast interferon. , 1978, Journal of immunology.

[53]  H. Strander,et al.  Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon , 1978, International journal of cancer.

[54]  J. Streilein,et al.  Lymphocyte traffic, T-cell malignancies and the skin. , 1978, The Journal of investigative dermatology.

[55]  B. Safai,et al.  Subpopulations of human T lymphocytes: IV. Quantitation and distribution in patients with mycosis fungoides and Sézary syndrome , 1978 .

[56]  S. Asbell,et al.  Antibody-dependent cellular cytotoxicity in patients with mycosis fungoides and Sézary syndrome. , 1978, International journal of radiation oncology, biology, physics.

[57]  E. V. Van Scott,et al.  Lymphocyte transformation in patients with staged mycosis fungoides and sezary syndrome , 1978, Cancer.

[58]  C. Baglioni,et al.  Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A , 1978, Nature.

[59]  G. Trinchieri,et al.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis , 1978, The Journal of experimental medicine.

[60]  G. Trinchieri,et al.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation , 1978, The Journal of experimental medicine.

[61]  B. Williams,et al.  Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts , 1978, Cell.

[62]  H. Roenigk,et al.  Selective immunological evaluation of mycosis fungoides. , 1978, Archives of dermatology.

[63]  W. Vloten,et al.  Delayed-type hypersensitivity in patients with mycosis fungoides. , 1978, Dermatologica.

[64]  G. Trinchieri,et al.  Tumour cell lines induce interferon in human lymphocytes , 1977, Nature.

[65]  W. Weston,et al.  Defective monocyte chemotaxis in mycosis fungoides. , 1977, Archives of dermatology.

[66]  A. Dobozy,et al.  Autoimmune anti‐T cell antibodies in the sera of patients with mycosis fungoides , 1977, The British journal of dermatology.

[67]  R. Jackson,et al.  Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis , 1977, Cell.

[68]  S. Asbell,et al.  Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results. , 1977, Archives of dermatology.

[69]  T. Waldmann,et al.  The Sézary syndrome: a malignant proliferation of helper T cells. , 1976, The Journal of clinical investigation.

[70]  R. Winkelmann,et al.  Macrophage inhibitor factor (MIF) in cutaneous lymphoproliferative diseases , 1976, The British journal of dermatology.

[71]  J. Kinney,et al.  T and B cells and cell‐mediated immunity in mycosis fungoides , 1976, Cancer.

[72]  T. Yoshida,et al.  Migration inhibitory activity in serum and cell supernatants in patients with Sezary syndrome. , 1975, Journal of Immunology.

[73]  S. Malka,et al.  Mycosis fungoides—a disease of antigen persistence , 1974, The British journal of dermatology.

[74]  E. Shevach,et al.  Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. , 1974, Annals of internal medicine.

[75]  J. Norris,et al.  Letter: G.A.B.A. in Huntington's chorea. , 1974, Lancet.

[76]  I. Gresser.  Antitumor effects of interferon. , 1978, Advances in cancer research.

[77]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[78]  W. Clendenning,et al.  Skin autografts and homografts in patients with the lymphoma mycosis fungoides , 1965 .

[79]  Wheelock Ef,et al.  CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. , 1965 .

[80]  T. Merigan,et al.  CIRCULATING INTERFERON AFTER MEASLES VACCINATION. , 1965, The New England journal of medicine.

[81]  D. Watkin,et al.  POSTOPERATIVE WOUND INFECTION. , 1965, Lancet.